CHAC1 and breast neoplasm: As mentioned above, on the basis of the increased expression of CHAC1 in HR-negative breast tumours, a stratified multivariate subgroup analysis might provide more insight and address the question, if the prognostic value of CHAC1 differs between patients with poorly differentiated or aggressive tumour cells and tumour entities with presence of HR on their surface.